Abstract
Unintentionally omitted from the recently published Special Issue, “Current Considerations for Development of Cannabinoid Receptor 1 Antagonists”, Volume 70, Issue 8 (December 2009), was the acknowledgement of Dr. Thomas's co-editors, Drs. Patrick M. Beardsley and Herbert H. Seltzman, and their co-authorship of the issue's opening editorial on pages 525–526 [DOI: 10.1002/ddr.20332]. Drs. Beardsley and Seltzman should also have been listed as Guest Editors of this special issue, in addition to Dr. Thomas. Herein reprinted with all Guest Editors' names, is the now-revised title page that preceded the articles in the special issue: Current Considerations for Development of Cannabinoid Receptor 1 Antagonists Guest Editors Brian F. Thomas Senior Director—Analytical Chemistry and Pharmaceutics Discovery and Analytical Sciences RTI International Research Triangle Park, North Carolina Patrick M. Beardsley Department of Pharmacology and Toxicology and Institute on Drug and Alcohol Abuse Virginia Commonwealth University Richmond, Virginia Herbert H. Seltzman Senior Research Scientist Center for Organic and Medicinal Chemistry RTI International Research Triangle Park, North Carolina
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
